Last updated: November 13, 2019
Sponsor: National University Hospital, Singapore
Overall Status: Active - Recruiting
Phase
N/A
Condition
Glaucoma
Treatment
N/AClinical Study ID
NCT04092400
DSRB - 2016/00125
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- are all patients with glaucoma who have been listed for implantation of micro-invasiveglaucoma surgical devices, with or without cataract surgery
Exclusion
Exclusion Criteria:
- Advanced glaucoma (as defined as cup-disc ratio ≥ 0.9 and/or a visual field defectwithin central 10˚ of fixation) ; diagnosis of glaucoma other than POAG and PACG (including uveitic, neovascular, traumatic glaucoma or glaucoma secondary to raisedepiscleral venous pressure); prior incisional glaucoma surgery or cataract surgery;presence of scarring, prior surgery or other conjunctival pathologies in the targetquadrant; presence of vitreous in the anterior chamber; presence of intraocularsilicone oil; clinically significant inflammation or infection in the study eye within 30 days before the pre-operative visit; known or suspected allergy or sensitivity todrugs required for the surgery (including anaesthesia) or any of the device components (eg. porcine products and glutaraldehyde); and any corneal, choroidal, retinal,orbital disease which may interfere with MIGS device implantation
Study Design
Total Participants: 500
Study Start date:
March 10, 2016
Estimated Completion Date:
December 31, 2020
Study Description
Connect with a study center
Chelvin Sng, National University Hospital Department of Ophthalmology
Singapore, 119228
SingaporeActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.